Skip to main content
. 2019 Jun 3;21(7):901–910. doi: 10.1093/neuonc/noz061

Fig. 4.

Fig. 4

Survival analysis of all WHO grade I (A), WHO grade II (B) and WHO grade III (C) tumors in all 3 validation cohorts stratified by methylation-based predictor risk groups.